NASDAQ Composite ended the session with Arena Pharmaceuticals jumping 2.86% to $80.55 on Thursday while nASDAQ Composite fell 0.04% to $13,123.94.

Arena Pharmaceuticals today’s close was $80.55, 11.97% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the present quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.


Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.71%, 0.48%, and 0.59%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 7.15%, 4.71%, and 3.72%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $80.55 at 16:36 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is way higher than its 50-day moving average of $72.38 and way above its 200-day moving average of $71.02.


Please enter your comment!
Please enter your name here